Philippe Müller

1.7k total citations · 1 hit paper
32 papers, 1.0k citations indexed

About

Philippe Müller is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Philippe Müller has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Philippe Müller's work include Coronary Interventions and Diagnostics (8 papers), Cardiac Valve Diseases and Treatments (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Philippe Müller is often cited by papers focused on Coronary Interventions and Diagnostics (8 papers), Cardiac Valve Diseases and Treatments (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Philippe Müller collaborates with scholars based in United Kingdom, United States and Netherlands. Philippe Müller's co-authors include Stefanie M. Brendecke, Tobias Goldmann, Marco Prinz, Yochai Wolf, Simon Yona, Ori Staszewski, Tom Luedde, Peter Wieghofer, Mathias Heikenwälder and Katrin Kierdorf and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Neuroscience.

In The Last Decade

Philippe Müller

31 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation

2013 516 citations Tobias Goldmann, Peter Wieghofer et al. Nature Neuroscience profile →

Peers

Countries citing papers authored by Philippe Müller

Since Specialization

Citations

This map shows the geographic impact of Philippe Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Müller more than expected).

Fields of papers citing papers by Philippe Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Müller. The network helps show where Philippe Müller may publish in the future.

Co-authorship network of co-authors of Philippe Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Müller. A scholar is included among the top collaborators of Philippe Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Müller. Philippe Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study 2025 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Helena Aicher, (unknown), Philippe Müller, (unknown), Maxim Puchkov, Angela Äbelö, Erich Seifritz, Boris B. Quednow, Robin von Rotz, Milan Scheidegger, Dario Dornbierer	3
2	Response to ‘Eruptive Keratoacanthomas Associated with Dupilumab Therapy’ 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Philippe Müller, Nadine Petitpain	0
3	Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent 2020 ·Catheterization and Cardiovascular Interventions ·(unknown), Jaya Chandrasekhar, Deborah N. Kalkman, Pier Woudstra, Ian Menown, Harry Suryapranata, Peter den Heijer, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Andrejs Ērglis, Karin Arkenbout, Philippe Müller, Karel T. Koch, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	6
4	Characterization of Flow-Caused Intrarenal Pressure Conditions During Percutaneous Nephrolithotomy In Vitro 2019 ·Journal of Endourology ·Konrad Wilhelm, Philippe Müller, (unknown), (unknown), (unknown), Arkadiusz Miernik, Stefan Schumann	9
5	Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry 2019 ·Cardiovascular revascularization medicine ·(unknown), Deborah N. Kalkman, Pier Woudstra, Ian Menown, Harry Suryapranata, Peter den Heijer, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Andrejs Ērglis, Karin Arkenbout, Philippe Müller, Karel T. Koch, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	2
6	Robotic waterjet wound debridement – Workflow adaption for clinical application and systematic evaluation of a novel technology 2018 ·PLoS ONE ·Dominik S. Schoeb, (unknown), Daniel Schlager, Philippe Müller, Arkadiusz Miernik, Thomas Bahls	8
7	Three‐year clinical outcomes after dual‐therapy COMBO stent placement: Insights from the REMEDEE registry 2018 ·Catheterization and Cardiovascular Interventions ·Deborah N. Kalkman, (unknown), Pier Woudstra, Ian Menown, Harry Suryapranata, Peter den Heijer, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Andrejs Ērglis, Karin Arkenbout, Philippe Müller, Karel T. Koch, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	7
8	1-Year Results of the REMEDEE Registry 2016 ·JACC: Cardiovascular Interventions ·Pier Woudstra, Deborah N. Kalkman, Peter den Heijer, Ian Menown, Andrejs Ērglis, Harry Suryapranata, Karin Arkenbout, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Philippe Müller, Jan G.P. Tijssen, Robbert J. de Winter	27
9	TCT-63 One Year Results Of The REMEDEE Registry: Clinical Outcomes After Deployment Of The Abluminal Sirolimus Coated Bio-Engineerd Stent In A Multicenter, Prospective Post Market Registry 2015 ·Journal of the American College of Cardiology ·Robbert J. de Winter, Peter den Heijer, Ian Menown, Andrejs Ērglis, Harry Suryapranata, Karin Arkenbout, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Philippe Müller, Pier Woudstra, Deborah N. Kalkman, Jan G.P. Tijssen	1
10	A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation breakdown → 2013 ·Nature Neuroscience ·Tobias Goldmann, Peter Wieghofer, Philippe Müller, Yochai Wolf, Diana Varol, Simon Yona, Stefanie M. Brendecke, Katrin Kierdorf, Ori Staszewski, Moumita Datta, Tom Luedde, Mathias Heikenwälder, Steffen Jung, Marco Prinz	516
11	Motion sickness on tilting trains 2011 ·The FASEB Journal ·Bernard Cohen, Mingjia Dai, (unknown), Jean Laurens, Theodore Raphan, Philippe Müller, Αθανάσιος Αλεξίου, (unknown), (unknown), (unknown), (unknown), (unknown), Dominik Straumann	10
12	Adiponectin and leptin in Afro-Caribbean men and women with HIV infection: Association with insulin resistance and type 2 diabetes 2010 ·Diabetes & Metabolism ·Jacqueline Deloumeaux, Mustapha Maachi, (unknown), I. Lamaury, (unknown), Antoine Chéret, (unknown), Philippe Müller, (unknown), Geneviève Chêne, Jacqueline Capeau, L. Foucan	5
13	Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulation 2010 ·AIDS ·(unknown), Philippe Müller, Thiérry Prazuck, (unknown), Eric Peyrouse, Christian Bernard, Yann Quertainmont, Élisabeth Bouvet, Christian Rabaud	38
14	Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121) 2008 ·Journal of Medicinal Chemistry ·Jean‐François Bonfanti, Christophe Meyer, (unknown), Jérôme Fortin, Philippe Müller, Laurence Quéguiner, Tom Gevers, (unknown), (unknown), Rudy Willebrords, Philip Timmerman, (unknown), P. Van Remoortere, Frans Janssens, Piet Wigerinck, Koen Andries	76
15	Integration of Bacteria Capture via Filtration and in Situ Lysis for Recovery of Plasmid DNA under Industry-Compatible Conditions 2007 ·Biotechnology Progress ·(unknown), Ruth Freitag, Frank Hilbrig, (unknown), Philippe Müller	6
16	Angiomatose bacillaire au cours du SIDA 2006 ·Annales de Dermatologie et de Vénéréologie ·(unknown), Antoine Chéret, Philippe Müller, (unknown), (unknown), I. Lamaury	1
17	Capture of Bacteria from Fermentation Broth by Body Feed Filtration: A Solved Problem? 2006 ·Biotechnology Progress ·(unknown), Ruth Freitag, (unknown), Frank Hilbrig, Philippe Müller, (unknown)	9
18	5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Patrick Angibaud, (unknown), Ann Devine, David W. End, Eddy Freyne, (unknown), Philippe Müller, Geert Mannens, (unknown), (unknown), (unknown), G. Smets, Jacky Van Dun, P. Van Remoortere, Marc Venet, Walter Wouters	27
19	Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Patrick Angibaud, (unknown), David W. End, Eddy Freyne, Michel Janicot, (unknown), (unknown), Geert Mannens, (unknown), Laurence Mévellec, Christophe Meyer, Philippe Müller, (unknown), (unknown), Bruno Roux, G. Smets, Jacky Van Dun, P. Van Remoortere, Marc Venet, Walter Wouters	19
20	Dengue Fever: A Harmful Disease in Patients with Thrombocytopenia? 2001 ·Clinical Infectious Diseases ·M Strobel, Philippe Müller, I. Lamaury, François Rouet	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact